Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1986 2
1987 10
1988 11
1989 11
1990 11
1991 19
1992 23
1993 31
1994 25
1995 23
1996 31
1997 22
1998 27
1999 26
2000 38
2001 33
2002 44
2003 56
2004 51
2005 59
2006 50
2007 59
2008 54
2009 64
2010 80
2011 75
2012 80
2013 84
2014 90
2015 91
2016 91
2017 116
2018 126
2019 123
2020 134
2021 148
2022 122
2023 138
2024 53

Text availability

Article attribute

Article type

Publication date

Search Results

1,052 results

Results by year

Filters applied: Meta-Analysis, Review, Systematic Review, in the last 10 years. Clear all
Page 1
Myelodysplastic Syndrome Updated.
Hasserjian RP. Hasserjian RP. Pathobiology. 2019;86(1):7-13. doi: 10.1159/000489702. Epub 2018 Jul 24. Pathobiology. 2019. PMID: 30041243 Free article. Review.
This review highlights the main changes in the revised 2016 WHO Classification of Myeloid Neoplasms (published in 2017) that impact the diagnosis and management of patients with myelodysplastic syndrome (MDS). The revision was based on data accumulated since the 200 …
This review highlights the main changes in the revised 2016 WHO Classification of Myeloid Neoplasms (published in 2017) that impact the diag …
Childhood Myelodysplastic Syndrome.
Chisholm KM, Bohling SD. Chisholm KM, et al. Clin Lab Med. 2023 Dec;43(4):639-655. doi: 10.1016/j.cll.2023.06.005. Epub 2023 Aug 7. Clin Lab Med. 2023. PMID: 37865508 Review.
Myelodysplastic syndrome (MDS) in children is rare, accounting for < 5% of all childhood hematologic malignancies. ...
Myelodysplastic syndrome (MDS) in children is rare, accounting for < 5% of all childhood hematologic malignancies. ...
The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia.
Rudelius M, Weinberg OK, Niemeyer CM, Shimamura A, Calvo KR. Rudelius M, et al. Virchows Arch. 2023 Jan;482(1):113-130. doi: 10.1007/s00428-022-03447-9. Epub 2022 Nov 29. Virchows Arch. 2023. PMID: 36445482 Review.
Updating the classification of hematologic neoplasia with germline predisposition, pediatric myelodysplastic syndrome (MDS), and juvenile myelomonocytic leukemia (JMML) is critical for diagnosis, therapy, research, and clinical trials. ...We also detail advances in …
Updating the classification of hematologic neoplasia with germline predisposition, pediatric myelodysplastic syndrome (MDS), a …
Pediatric myelodysplastic syndrome.
Babcock S, Calvo KR, Hasserjian RP. Babcock S, et al. Semin Diagn Pathol. 2023 May;40(3):152-171. doi: 10.1053/j.semdp.2023.04.006. Epub 2023 Apr 14. Semin Diagn Pathol. 2023. PMID: 37173164 Review. No abstract available.
Myelodysplastic syndrome with genetic predisposition.
Park M. Park M. Blood Res. 2021 Apr 30;56(S1):S34-S38. doi: 10.5045/br.2021.2020327. Blood Res. 2021. PMID: 33935033 Free PMC article. Review.
Myelodysplastic syndrome (MDS) refers to a heterogeneous group of clonal blood disorders characterized by ineffective hematopoiesis, cytopenia, dysplasia, and an increased risk of acute myeloid leukemia (AML). ...
Myelodysplastic syndrome (MDS) refers to a heterogeneous group of clonal blood disorders characterized by ineffective hematopo …
Epidemiology and Pathogenesis of Myelodysplastic Syndrome.
Rotter LK, Shimony S, Ling K, Chen E, Shallis RM, Zeidan AM, Stahl M. Rotter LK, et al. Cancer J. 2023 May-Jun 01;29(3):111-121. doi: 10.1097/PPO.0000000000000665. Cancer J. 2023. PMID: 37195766 Review.
Myelodysplastic syndrome (MDS) is a clonal disorder characterized by ineffective hematopoiesis and variable cytopenias with a considerable risk of progression to acute myeloid leukemia. ...
Myelodysplastic syndrome (MDS) is a clonal disorder characterized by ineffective hematopoiesis and variable cytopenias with a …
Myelodysplastic Syndrome: Diagnosis and Screening.
Tria FP 4th, Ang DC, Fan G. Tria FP 4th, et al. Diagnostics (Basel). 2022 Jun 29;12(7):1581. doi: 10.3390/diagnostics12071581. Diagnostics (Basel). 2022. PMID: 35885487 Free PMC article. Review.
Genomics of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.
Patnaik MM, Lasho TL. Patnaik MM, et al. Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):450-459. doi: 10.1182/hematology.2020000130. Hematology Am Soc Hematol Educ Program. 2020. PMID: 33275756 Free PMC article. Review.
Myelodysplastic syndrome (MDS)/myeloproliferative neoplasm (MPN) overlap syndromes are uniquely classified neoplasms occurring in both children and adults. ...
Myelodysplastic syndrome (MDS)/myeloproliferative neoplasm (MPN) overlap syndromes are uniquely classified neoplasms occurring …
Molecular Targeted Therapy and Immunotherapy for Myelodysplastic Syndrome.
Lee P, Yim R, Yung Y, Chu HT, Yip PK, Gill H. Lee P, et al. Int J Mol Sci. 2021 Sep 23;22(19):10232. doi: 10.3390/ijms221910232. Int J Mol Sci. 2021. PMID: 34638574 Free PMC article. Review.
Myelodysplastic syndrome (MDS) is a heterogeneous, clonal hematological disorder characterized by ineffective hematopoiesis, cytopenia, morphologic dysplasia, and predisposition to acute myeloid leukemia (AML). ...
Myelodysplastic syndrome (MDS) is a heterogeneous, clonal hematological disorder characterized by ineffective hematopoiesis, c …
1,052 results